Manning & Napier Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | $192M | Sell |
2,065,710
-52,776
| -2% | -$4.91M | 1.65% | 20 |
|
|
2017
Q2 | $192M | Buy |
2,118,486
+426,016
| +25% | +$38.7M | 1.65% | 21 |
|
|
2017
Q1 | $149M | Sell |
1,692,470
-335,460
| -17% | -$29.4M | 1.15% | 37 |
|
|
2016
Q4 | $168M | Buy |
2,027,930
+1,885,520
| +1,324% | +$156M | 1.1% | 35 |
|
|
2016
Q3 | $13.2M | Buy |
142,410
+2,490
| +2% | +$230K | 0.08% | 95 |
|
|
2016
Q2 | $10.9M | Buy |
+139,920
| New | +$10.9M | 0.07% | 112 |
|
|
2015
Q1 | – | Sell |
-288,180
| Closed | -$26.1M | – | 371 |
|
|
2014
Q4 | $26.1M | Hold |
288,180
| – | – | 0.12% | 103 |
|
|
2014
Q3 | $20.8M | Buy |
288,180
+44,120
| +18% | +$3.18M | 0.09% | 121 |
|
|
2014
Q2 | $15.2M | Buy |
244,060
+72,550
| +42% | +$4.51M | 0.06% | 142 |
|
|
2014
Q1 | $11.7M | Buy |
+171,510
| New | +$11.7M | 0.05% | 156 |
|